Collective Medical, a large effective network for care collaboration, announced that California emergency department (ED) physicians now have access to California’s Controlled Substance Utilization Review and Evaluation System (CURES 2.0) prescription drug data through the Collective Platform. The integration between CURES 2.0 and the Collective Platform simplifies physician workflow to ensure ED providers have essential opioid prescription history information about a patient in real-time at the point of care.
CURES 2.0 Integration Will Improve ED Provider Experience
The Collective Network has been proven to help care teams combat the opioid epidemic across the nation. In addition to similar PDMP integrations in numerous states, Collective arms ED providers with holistic information about patients through its platform’s Insights™ functionality, including information on possible social determinants, safety, and security alerts, utilization patterns across all points of care and care team contact information. Integration with CURES 2.0 will simplify and enrich the ED provider experience in California, supporting them in making the most appropriate care decisions, and amplifying the impact of the CURES 2.0 database for patients across the state.
California Assembly Bill 40 (AB 40) Overview
California Assembly Bill 40 (AB 40) was passed into law in October 2017, allowing healthcare practitioners and pharmacists to submit a query to the CURES database through a health information technology system, such as the Collective Platform. Following the passage of AB 40, the California Department of Justice CURES 2.0 Program implemented new technical innovations to enable authorized healthcare practitioners and pharmacists at hospitals across the state of California to connect to the CURES 2.0 database.
Holistic View of Patient Data
With a more holistic view of the patient, provided both through the Collective Platform’s Insights functionality and CURES 2.0, care teams have an opportunity to do more than simply avoid writing a prescription for narcotics. Armed with more comprehensive information, providers can consider novel treatment models, such as ED Bridge, which supports EDs throughout California to develop and implement plans for 24/7 access to buprenorphine for patients with opioid use disorder as a ‘bridge’ into outpatient medication-assisted treatment.
A recent article by the New York Times covering ED Bridge mentioned a study out of Yale-New Haven Hospital found that addicted patients were given buprenorphine in the ED where twice as likely to be in treatment a month later as those who were provided with typical patient education materials.
Currently, the Collective Network is live in states across the country including Washington, California, Oregon, Massachusetts, Virginia, West Virginia, Alaska, New Mexico, and many others. Collective’s real-time, risk-adjusted event notification and care collaboration platform serve all points of care, including the emergency department, inpatient, post-acute, mental and behavioral, and ambulatory settings, as well as ACOs and health plans.
